Home/Filings/4/0001144204-15-037757
4//SEC Filing

Pulmatrix, Inc. 4

Accession 0001144204-15-037757

$PULMCIK 0001574235operating

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 8:26 PM ET

Size

22.5 KB

Accession

0001144204-15-037757

Insider Transaction Report

Form 4
Period: 2015-06-15
Clarke Robert W.
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2015-06-15+2,4132,413 total
    Exercise: $2.20Exp: 2020-05-24Common Stock (2,413 underlying)
  • Award

    Stock Option (Right to Buy)

    2015-06-15+65,62665,625 total
    Exercise: $1.88Exp: 2023-10-11Common Stock (65,625 underlying)
  • Award

    Stock Option (Right to Buy)

    2015-06-15+11,85511,855 total
    Exercise: $2.20Exp: 2021-06-15Common Stock (11,855 underlying)
  • Award

    Stock Option (Right to Buy)

    2015-06-15+171,009171,009 total
    Exercise: $2.03Exp: 2022-09-18Common Stock (171,009 underlying)
  • Award

    Stock Option (Right to Buy)

    2015-06-16+407,907407,907 total
    Exercise: $11.80Exp: 2025-06-16Common Stock (407,907 underlying)
  • Award

    Common Stock

    2015-06-15+18,66718,667 total
  • Award

    Stock Option (Right to Buy)

    2015-06-15+7,1907,190 total
    Exercise: $2.20Exp: 2020-02-10Common Stock (7,190 underlying)
  • Award

    Stock Option (Right to Buy)

    2015-06-15+23,71023,710 total
    Exercise: $2.03Exp: 2022-06-08Common Stock (23,710 underlying)
Footnotes (12)
  • [F1]Reflects a 1-for-2.5 reverse stock split effected on June 15, 2015.
  • [F10]These securities were received in the Merger in exchange for a stock option to acquire 1,071,120 shares for $0.11 per share of common stock of the Former Entity.
  • [F11]These options vested/vest over a four-year period, with 50% vesting on the first anniversary of the initial date of grant by the Former Entity and 4.167% vesting each month thereafter for twelve months.
  • [F12]These options vest as to 25% on June 15, 2016 and 2.08% monthly thereafter. In the event of a change of control of the Issuer, the option shall become vested in full.
  • [F2]On June 15, 2015, the Reporting Person received these shares of the Issuer's Common Stock in exchange for securities of a private company formerly known as Pulmatrix, Inc. (the "Former Entity") in connection with the merger of the Former Entity into the Issuer (the "Merger").
  • [F3]These securities were received in the Merger in exchange for a stock option to acquire 121,293 shares for $0.13 per share of common stock of the Former Entity.
  • [F4]These options are fully vested and exercisable.
  • [F5]These securities were received in the Merger in exchange for a stock option to acquire 40,699 shares for $0.13 per share of common stock of the Former Entity.
  • [F6]These securities were received in the Merger in exchange for a stock option to acquire 200,000 shares for $0.13 per share of common stock of the Former Entity.
  • [F7]These options vested/vest over a four-year period, with 25% vesting on the first anniversary of the initial date of grant by the Former Entity and 2.083% vesting each month thereafter for thirty-six months.
  • [F8]These securities were received in the Merger in exchange for a stock option to acquire 400,000 shares for $0.12 per share of common stock of the Former Entity.
  • [F9]These securities were received in the Merger in exchange for a stock option to acquire 2,885,000 shares for $0.12 per share of common stock of the Former Entity.

Issuer

Pulmatrix, Inc.

CIK 0001574235

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001574235

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 8:26 PM ET
Size
22.5 KB